Answers are grounded in this paper and cite their sources.
JAK kinase inhibitors are being investigated as a way of managing cytokine storm in severe COVID-19 patients.
No takes yet. Share an insight, caveat, or question.
Spinelli et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: